Cyclerion Therapeutics (CYCN) Profit After Tax (QoQ) (2018 - 2025)
Cyclerion Therapeutics (CYCN) Profit After Tax (QoQ) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Cyclerion Therapeutics |
11.94 Mn |
8.70 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-201.23% |
| Jun 30, 2025 |
77.33% |
| Mar 31, 2025 |
-369.62% |
| Dec 31, 2024 |
173.31% |
| Sep 30, 2024 |
45.31% |
| Jun 30, 2024 |
14.27% |
| Mar 31, 2024 |
8.97% |
| Dec 31, 2023 |
71.33% |
| Sep 30, 2023 |
-41.31% |
| Jun 30, 2023 |
39.88% |
| Mar 31, 2023 |
-60.86% |
| Dec 31, 2022 |
58.81% |
| Sep 30, 2022 |
21.60% |
| Jun 30, 2022 |
-3.16% |
| Mar 31, 2022 |
-20.45% |
| Dec 31, 2021 |
4.56% |
| Sep 30, 2021 |
30.23% |
| Jun 30, 2021 |
-132.70% |
| Mar 31, 2021 |
63.83% |
| Dec 31, 2020 |
-2.21% |
